The FDA this month vowed to create clearer regulations for cannabidiol, pushing the cannabis-derived compound even further into the consumer mainstream. Read More
Analyst Articles
Q4 2020 revenue is up but profits are down, pointing to pressure on profit margins. We examine whether investors should worry. Read More
The cannabis industry is all the rage, but you need to apply the proper criteria before investing your hard-earned money. Read More
Factors currently boosting stocks could also act as accelerants during the next market tumble. Investors should take the stairs, not the elevator. Read More
We’ve enjoyed a rally since the November 3 election, but are stocks now excessively valued and set for a correction? We asked an in-house expert. Read More
Here’s a look at the latest investment inquiries from readers, with responses that provide actionable advice. Read More
The advent of a new U.S. president has cheered investors, but stocks are overvalued and could be poised for a tumble. Here's how to trade. Read More
The Empire State is moving toward legalization of recreational pot, paving the way for a vast new source of sales and investment profits. Read More
The recovery from the pandemic-induced recession is still underway but slowing. How optimistic (or worried) should you be? Read More
Wall Street expects coronavirus relief legislation to repair the economy and lift equity assets. Here’s a look at the incoming political reality. Read More